81235 Egfr gene com variants
Also known as: EGFR mutation testing, EGFR common variant panel
Molecular analysis of the EGFR gene to identify common mutations associated with non-small cell lung cancer.
In Plain Language
lung cancer gene test; targeted therapy mutation screening
Clinical Context
Used to identify EGFR mutations in non-small cell lung cancer for EGFR tyrosine kinase inhibitor eligibility and treatment selection.
RVU Information
CPT 81235 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81235?
CPT 81235 (Egfr gene com variants) is a Pathology & Lab code. Molecular analysis of the EGFR gene to identify common mutations associated with non-small cell lung cancer.
Who uses CPT code 81235?
CPT 81235 is used by Oncology, Pathology, Pulmonology. Used to identify EGFR mutations in non-small cell lung cancer for EGFR tyrosine kinase inhibitor eligibility and treatment selection.
When is CPT 81235 used?
Used to identify EGFR mutations in non-small cell lung cancer for EGFR tyrosine kinase inhibitor eligibility and treatment selection.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.